Townson Sharon 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Townson Sharon
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+161,000→ 161,000 totalExercise: $7.11Exp: 2035-01-01→ Common Stock (161,000 underlying) - Award
Common Stock
2025-01-02+36,000→ 36,000 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 1, 2026, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]25% of this option shall vest and become exercisable on January 1, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.